CRBP Insider Trading Activity and SEC Form 4 Filings
CRBP insider trading summary
Over the past 12 months, insiders at Corbus Pharmaceuticals Holdings, Inc. (CRBP) reported 18 sales worth $6.9M by 11 insiders and 3 open-market purchases worth $126K by 1 insider on SEC Form 4. Net insider selling was $6.8M.
Latest CRBP insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 29, 2026 | Cormorant Asset Management, LP | Insider | Sell | $1.7M (425,000 @ $4.10) |
| Oct 29, 2026 | Cormorant Global Healthcare Master Fund, LP | Insider | Sell | $1.7M (425,000 @ $4.10) |
| Oct 29, 2026 | Bihua Chen | Insider | Sell | $1.7M (425,000 @ $4.10) |
| Sep 14, 2026 | Yong Ben | Insider | Sell | $16K (2,000 @ $7.84) |
| Aug 11, 2026 | Nishant C Saxena | Chief Business Officer | Buy | $25K (2,600 @ $9.63) |
| Aug 7, 2026 | Sean F. Moran | Chief Financial Officer | Sell | $121K (12,000 @ $10.08) |
| Aug 7, 2026 | Yuval Cohen | Chief Executive Officer | Sell | $171K (17,000 @ $10.08) |
| Jun 10, 2026 | Winston Kung | Insider | Sell | $16K (2,026 @ $7.91) |
| Jun 10, 2026 | John Kenneth Jenkins | Insider | Sell | $38K (4,800 @ $7.91) |
| Jun 10, 2026 | Anne Altmeyer | Insider | Sell | $19K (2,412 @ $7.91) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.